Company news

Neuronetics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Neuronetics Announces Retirement of Gregory Harper, Vice President, R&D and Clinical

March 10, 2021

Neuronetics Enhances TrakStar® Cloud Patient Data Management System to Maximize Physician Efficiencies

March 8, 2021

Neuronetics Names Cory Anderson Vice President, Clinical Affairs and Medical Operations

March 2, 2021

Neuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating Results

March 1, 2021

Neuronetics Announces Strategic Leadership Promotions to Support Future Growth

February 10, 2021

Neuronetics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

February 1, 2021

Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock

January 27, 2021

Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results

January 11, 2021

Neuronetics Announces Expansion of Sales Organization

January 6, 2021

Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners

December 7, 2020

Neuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol

November 22, 2020

Neuronetics Reports Third Quarter 2020 Financial and Operating Results

November 1, 2020

Neuronetics Appoints Sara Grubbs as Vice President, Sales

October 4, 2020

NeuroStar® Advanced Therapy Providers Offer Free TMS Consultations During National Depression Awareness Month

September 30, 2020

Neuronetics® Celebrates 500,000 Treatment Milestone for Greenbrook® TMS

September 28, 2020

Neuronetics Reports Second Quarter 2020 Financial and Operating Results

August 3, 2020

Neuronetics Announces the Appointment of Keith J. Sullivan as President and Chief Executive Officer

July 13, 2020

Neuronetics Announces Appointment of Bruce J. Shook to its Board of Directors

June 25, 2020

Neuronetics, Inc. Announces Virtual 2020 Annual Meeting of Stockholders

May 11, 2020

Neuronetics Reports First Quarter 2020 Financial and Operating Results

May 4, 2020

Neuronetics, Inc. Adopts Limited Duration Shareholder Rights Plan

April 7, 2020

Neuronetics® Hits Major Milestones with More Than 2.5 Million Treatments and 1,000 Installations of Its NeuroStar® Advanced Therapy System

March 15, 2020

FDA Grants NeuroStar® Advanced Therapy System Breakthrough Device Designation to Treat Bipolar Depression

March 5, 2020

Neuronetics, Inc. announces Chris Thatcher will step down as President and CEO

March 4, 2020

Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

March 2, 2020

Neuronetics Appoints Andrew Macan As Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary

January 20, 2020

Neuronetics Reports Third Quarter 2019 Financial and Operating Results

November 4, 2019

Neuronetics® Announces Appointment of Sheryl Conley to its Board of Directors

October 31, 2019

Neuronetics® and Success TMS Partner to Increase Patient Access to Leading Depression Treatment, NeuroStar® Advanced Therapy

October 27, 2019

Neuronetics® Announces Greenbrook® TMS Installation Milestone for NeuroStar® Advanced Therapy System

September 3, 2019

Neuronetics® Announces First TMS Patient Treated Under New Japan Reimbursement Policy

July 31, 2019

Neuronetics® Launches TrakStar® Plus Patient Data Management System to Maximize Physician Time with Patients

July 28, 2019

← Newer news releases

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 14 decks. Every deck is listed under its year.